Annual SG&A:
$0.00-$22.32M(-100.00%)Summary
- As of today, MLTX annual SG&A is $0.00, with the most recent change of -$22.32 million (-100.00%) on December 31, 2024.
- During the last 3 years, MLTX annual SG&A has fallen by -$18.05 million (-100.00%).
- MLTX annual SG&A is now -100.00% below its all-time high of $23.01 million, reached on December 31, 2022.
Performance
MLTX SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$0.00-$11.03M(-100.00%)Summary
- As of today, MLTX quarterly SG&A is $0.00, with the most recent change of -$11.03 million (-100.00%) on June 30, 2025.
- Over the past year, MLTX quarterly SG&A has dropped by -$6.92 million (-100.00%).
- MLTX quarterly SG&A is now -100.00% below its all-time high of $11.03 million, reached on March 31, 2025.
Performance
MLTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$1.03B-$176.16M(-20.59%)Summary
- As of today, MLTX TTM SG&A is -$1.03 billion, with the most recent change of -$176.16 million (-20.59%) on June 30, 2025.
- Over the past year, MLTX TTM SG&A has dropped by -$1.06 billion (-4061.86%).
- MLTX TTM SG&A is now -20637410.00% below its all-time high of -$5000.00.
Performance
MLTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
MLTX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -100.0% | -100.0% | -4061.9% |
| 3Y3 Years | -100.0% | -100.0% | -3976.1% |
| 5Y5 Years | -100.0% | 0.0% | -100.0% |
MLTX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -100.0% | at low | -100.0% | at low | -440.6% | at low |
| 5Y | 5-Year | -100.0% | at low | -100.0% | at low | >-9999.0% | at low |
| All-Time | All-Time | -100.0% | at low | -100.0% | at low | >-9999.0% | at low |
MLTX Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $18.40M(-27.3%) |
| Mar 2025 | - | $11.03M(>+9900.0%) | $25.32M(+20.0%) |
| Dec 2024 | $0.00(-100.0%) | $0.00(-100.0%) | $21.10M(-24.7%) |
| Sep 2024 | - | $7.38M(+6.7%) | $28.03M(+7.6%) |
| Jun 2024 | - | $6.92M(+1.6%) | $26.05M(+10.3%) |
| Mar 2024 | - | $6.81M(-1.8%) | $23.61M(+5.8%) |
| Dec 2023 | $22.32M(-3.0%) | $6.93M(+28.6%) | $22.32M(+7.7%) |
| Sep 2023 | - | $5.39M(+20.3%) | $20.72M(-1.7%) |
| Jun 2023 | - | $4.48M(-18.8%) | $21.07M(-7.7%) |
| Mar 2023 | - | $5.52M(+3.6%) | $22.84M(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $23.01M(+27.5%) | $5.33M(-7.3%) | $22.81M(-14.8%) |
| Sep 2022 | - | $5.75M(-8.1%) | $26.77M(+0.6%) |
| Jun 2022 | - | $6.25M(+13.9%) | $26.62M(+14.8%) |
| Mar 2022 | - | $5.49M(-40.9%) | $23.18M(+30.3%) |
| Dec 2021 | $18.05M(>+9900.0%) | $9.28M(+65.9%) | $17.79M(+106.7%) |
| Sep 2021 | - | $5.60M(+98.9%) | $8.61M(+186.0%) |
| Jun 2021 | - | $2.81M(+2891.3%) | $3.01M(+1444.2%) |
| Mar 2021 | - | $94.10K(-6.6%) | $194.90K(+93.4%) |
| Dec 2020 | $105.80K | $100.80K(>+9900.0%) | $100.80K(>+9900.0%) |
| Sep 2020 | - | $0.00 | $0.00 |
FAQ
- What is MoonLake Immunotherapeutics annual SG&A?
- What is the all-time high annual SG&A for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual SG&A year-on-year change?
- What is MoonLake Immunotherapeutics quarterly SG&A?
- What is the all-time high quarterly SG&A for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly SG&A year-on-year change?
- What is MoonLake Immunotherapeutics TTM SG&A?
- What is the all-time high TTM SG&A for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM SG&A year-on-year change?
What is MoonLake Immunotherapeutics annual SG&A?
The current annual SG&A of MLTX is $0.00
What is the all-time high annual SG&A for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual SG&A is $23.01M
What is MoonLake Immunotherapeutics annual SG&A year-on-year change?
Over the past year, MLTX annual SG&A has changed by -$22.32M (-100.00%)
What is MoonLake Immunotherapeutics quarterly SG&A?
The current quarterly SG&A of MLTX is $0.00
What is the all-time high quarterly SG&A for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly SG&A is $11.03M
What is MoonLake Immunotherapeutics quarterly SG&A year-on-year change?
Over the past year, MLTX quarterly SG&A has changed by -$6.92M (-100.00%)
What is MoonLake Immunotherapeutics TTM SG&A?
The current TTM SG&A of MLTX is -$1.03B
What is the all-time high TTM SG&A for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM SG&A is -$5000.00
What is MoonLake Immunotherapeutics TTM SG&A year-on-year change?
Over the past year, MLTX TTM SG&A has changed by -$1.06B (-4061.86%)